Skip to main content
Premium Trial:

Request an Annual Quote

FDA Official Says Pharmacogenomics Guidance to be Made Available Within a Week or Two

NEW ORLEANS, March 8 (GenomeWeb News) - The US Food and Drug Administration's guidance for pharmacogenomics data submissions will be available on a special FDA web site within a week, an FDA official said during a lecture at the Society of Toxicology meeting, held here this week.


Crystal Rice, a spokesperson for the FDA's Center for Drug Evaluation and Research, said the long-awaited full document is planned for release "within the next week or two."


One of the major questions that industry members still have about the voluntary submissions guidelines is the process by which individual biomarkers will be defined as "known, valid biomarkers," said Bill Pennie, director of molecular and investigative toxicology at Pfizer.


The FDA currently favors the use of expert advisory committees or public scientific organizations to decide which biomarkers qualify as known, valid biomarkers, said Goodsaid.


The widely anticipated document, whose approval  has been delayed numerous times since it was released as a draft in November 2003, is designed to encourage drug makers to use pharmacogenomics technologies in their drug-discovery efforts and submit some of their findings as a way to help the FDA broaden its knowledge of the technologies.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.